Replies to post #2619 on OncoSec Medical Inc (ONCSQ)

[zendeli]

Meeting

These data are also being orally presented at a parallel scientific symposium, hosted by OncoSec, titled "Electrogenetherapy: Intralesional Immunotherapy Approach for Skin Cancers Using Electroporation." Drs. Adil Daud and Axel Hauschild will chair the event, which will be held on Thursday, November 15 from 6:00-7:00pm Barcelona time. The agenda is as follows:

- Application and Versatility of Electrogenetherapy – Dr. Richard Heller
- Clinical Experience: Case presentation and discussion of intralesional injection of plasmid interleukin-12 with electroporation – Dr. Adil Daud
- Immune correlates and biomarkers: Immune related responses following intralesional injection of plasmid interleukin-12 with electroporation – Dr. David Weiner and Dr. Edward Cha
- Outlook on intralesional immunotherapies for the treatment of metastatic melanoma – Dr. Adil Daud